Ozone, apoE4, aging, and Alzheimer's disease
Ozone, apoE4, aging, and Alzheimer's disease
批准号:
8621919
负责人:
RUI-MING LIU
金额:
$22.04万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2015-06-30
关键词:
APP-PS1AccountingAgeAgingAir PollutantsAir PollutionAllelesAlzheimer disease preventionAlzheimer&aposs DiseaseAnimal ModelAnimalsApolipoprotein EAreaBrainBreathingChildCodeDataDementiaDendritic SpinesDevelopmentEarly Onset Familial Alzheimer&aposs DiseaseElderlyEnvironmental Risk FactorEpidemiologyEtiologyExhibitsExposure toFoundationsFree RadicalsFunctional disorderGasesGene MutationGene TargetingGenesGlutathioneGlutathione DisulfideHealthHippocampus (Brain)HumanInvestigationLate Onset Alzheimer DiseaseLeadLearningLifeLightLipid PeroxidationLipidsLong-Term PotentiationLungMemoryMemory LossMitochondriaMusNeurodegenerative DisordersOrganOxidantsOxidative StressOzonePathogenesisPathologyPlayPopulationPredispositionPreventionPrevention strategyProductionProtein IsoformsProteinsProtocols documentationRecoveryReportingRespiratory SystemRoleSynapsesSynaptic TransmissionTestingTissuesUnited StatesWild Type Mouseage relatedair filterapolipoprotein E-3apolipoprotein E-4basebody systemdensityeffective therapyexperienceexposed human populationgenetic risk factormalemorris water mazemouse modelneuron lossnovelnovel strategiesobject recognitionoxidationpollutantpublic health relevancesynaptic functiontoxicanturban areayoung adult
中文摘要
迟发性(散发性)阿尔茨海默病(AD)是一种与年龄有关的神经退行性疾病
英文摘要
The cause for late-onset (sporadic) Alzheimer's disease (AD), an aging-related neurodegenerative disease, is
unknown. Apolipoprotein E (apoE) is a major lipid transporter that exists in three isoforms (E2, E3, and E4) in
human, coded by 3 distinct alleles e2, e3, and e4. Both epidemiology and animal studies indicate that, beside
age, APOE e4 is a major genetic risk factor for AD, although the underlying mechanism remains largely
elusive. Expression of apoE4 alone, even in old ages, however, is insufficient to cause AD, suggesting that
other factors including environmental factors also play a role in the development of AD in this genetically
predisposed population. Ozone (O3) is a highly reactive gas and one of the most abundant urban pollutants with
over 30% of the population in the United States living in areas with unhealthy levels of O3. Although O3 is
traditionally considered to be a lung toxicant, emerging evidence indicates that O3 inhalation also causes oxidative
stress and pathological changes in other tissues/organs beyond the respiratory system. Interestingly, it has been
reported that children and young adults living in urban areas with high levels of air pollution including O3 exhibited
AD-like pathology in their brain. Our preliminary studies further show that cyclic O3 exposure, a situation that
mimics human exposure, accelerates memory loss in APP/PS1 mice, a well-established animal model of AD,
with no significant effect in wild type mice. We also show that O3 exposure induces oxidative stress and
neuronal cell death in the cortex and hippocampus of APP/PS1 mice. Together, the data suggest that although
O3 alone may not cause AD, it may increase the susceptibility of genetically predisposed population to AD. As
oxidative stress contributes importantly to AD pathogenesis and increases with age, and as apoE4 mice show
increased sensitivity to oxidative stress, we hypothesize that O3 exposure synergizes with genetic risk factor
apoE4 and aging, leading to the development of late-onset AD. We will test our hypothesis in two specific
aims using human apoE4 and apoE3 (represents the majority of human population who carry the APOE e3
gene) targeted replacement (TR) mouse models. In Aim 1, we will test whether cyclic O3 exposure accelerates
memory loss in apoE4 TR mice and whether aging will further exacerbate O3 effect. In Aim 2, we will test
whether apoE4 TR mice are more sensitive to O3-induced oxidative stress, synaptic dysfunction, and neuronal
cell death than apoE3 TR mice and whether aging further increases such sensitivity. The results from these
studies will not only shed new lights on the etiology of AD but also build a foundation for further investigation
of the interactions between O3 or other environmental risk factors, apoE4, and aging in the development of late-
onset AD. The results will have major impact in the field and may lead to the development of novel strategies
for the prevention and treatment of AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sex-dependent synergy between O3 exposure, APOE4 e4 genotype, and aging in the onset of Alzheimer's disease
-
批准号:10584765
-
项目类别:
-
资助金额:$44.14万
-
财政年份:2023
-
负责人:RUI-MING LIU
-
依托单位:
Core E Research Support
-
批准号:10560522
-
项目类别:
-
资助金额:$7.76万
-
财政年份:2020
-
负责人:RUI-MING LIU
-
依托单位:
Core E Research Support
-
批准号:10337086
-
项目类别:
-
资助金额:$7.82万
-
财政年份:2020
-
负责人:RUI-MING LIU
-
依托单位:
PAI-1 and aging-related susceptibility to lung fibrosis
-
批准号:9336422
-
项目类别:
-
资助金额:$43.84万
-
财政年份:2016
-
负责人:RUI-MING LIU
-
依托单位:
Ozone, apoE4, aging, and Alzheimer's disease
-
批准号:8741923
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2013
-
负责人:RUI-MING LIU
-
依托单位:
Animal Core
-
批准号:10218249
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2013
-
负责人:RUI-MING LIU
-
依托单位:
Glutathione and Lung Fibrosis
-
批准号:7895651
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2008
-
负责人:RUI-MING LIU
-
依托单位:
Glutathione and Lung Fibrosis
-
批准号:7527229
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2008
-
负责人:RUI-MING LIU
-
依托单位:
Glutathione and Lung Fibrosis
-
批准号:7691813
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2008
-
负责人:RUI-MING LIU
-
依托单位:
Glutathione deficiency & immune dysfunction during aging
-
批准号:6830308
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2002
-
负责人:RUI-MING LIU
-
依托单位:
Glutathione deficiency & immune dysfunction during aging
-
批准号:6621756
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2002
-
负责人:RUI-MING LIU
-
依托单位:
Glutathione deficiency & immune dysfunction during aging
-
批准号:6686002
-
项目类别:
-
资助金额:$21.53万
-
财政年份:2002
-
负责人:RUI-MING LIU
-
依托单位:
Glutathione deficiency & immune dysfunction during aging
-
批准号:6989757
-
项目类别:
-
资助金额:$21.02万
-
财政年份:2002
-
负责人:RUI-MING LIU
-
依托单位:
Glutathione deficiency & immune dysfunction during aging
-
批准号:6436397
-
项目类别:
-
资助金额:$24.03万
-
财政年份:2002
-
负责人:RUI-MING LIU
-
依托单位:
GLUTAMYLCYSTEUBE SYNTHETASE AND AGING
-
批准号:2705994
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1998
-
负责人:RUI-MING LIU
-
依托单位:
GLUTAMYLCYSTEUBE SYNTHETASE AND AGING
-
批准号:6131813
-
项目类别:
-
资助金额:$6.05万
-
财政年份:1998
-
负责人:RUI-MING LIU
-
依托单位:
Animal and Therapeutics Core
-
批准号:8735182
-
项目类别:
-
资助金额:$32.88万
-
财政年份:--
-
负责人:RUI-MING LIU
-
依托单位:
Animal and Therapeutics Core
-
批准号:8582306
-
项目类别:
-
资助金额:$31.94万
-
财政年份:--
-
负责人:RUI-MING LIU
-
依托单位:
Animal Core
-
批准号:9752653
-
项目类别:
-
资助金额:$19.75万
-
财政年份:--
-
负责人:RUI-MING LIU
-
依托单位:
Animal and Therapeutics Core
-
批准号:9115707
-
项目类别:
-
资助金额:$32.29万
-
财政年份:--
-
负责人:RUI-MING LIU
-
依托单位:
海外基金